Nasopharyngeal carcinoma

Advocacy intelligence hub — real-time data for patient organizations

View full disease page →Search clinical trials →

At a Glance

Live from database

1FDA treatments

89Recruiting trials

Regulatory Watchboard

10 events

Aug 2026Testing Whether Cemiplimab (REGN2810) Plus CDX-1140 Given Prior to Surgery Are Better Than Cemiplimab (REGN2810) Alone in Patients With Stage III-IV Head and Neck Cancer

National Cancer Institute (NCI) — PHASE2

TrialRECRUITING

Mar 2026Toripalimab Combined With Different Platinum-Based Induction Chemotherapy Regimens for Locally Advanced Nasopharyngeal Carcinoma

Sun Yat-sen University — PHASE2

TrialRECRUITING

Mar 2026Timing Optimization of Immunotherapy During Neoadjuvant Chemotherapy for Locally Advanced Nasopharyngeal Carcinoma

Fujian Cancer Hospital — PHASE2

TrialNOT YET RECRUITING

Feb 2026Hypofractionated Radiotherapy for Nasopharyngeal Carcinoma

The Second Affiliated Hospital of Hainan Medical University — NA

TrialRECRUITING

Feb 2026Envafolimab Combined With Chemoradiotherapy and Recombinant Human Endostatin for LA-NPC.

Chongqing University Cancer Hospital — PHASE2

TrialRECRUITING

Feb 2026PD-1 Inhibitor Plus Chemotherapy Followed by Immediate Versus Selective Re-irradiation for Locally Advanced Recurrent NPC

Sun Yat-sen University — PHASE2

TrialRECRUITING

Feb 2026CROSSROAD: Treatment Regimen Switch - Re-induction Chemotherapy vs. Direct Radiotherapy in LANPC With Inadequate Response to Induction Chemotherapy

Fujian Cancer Hospital

TrialNOT YET RECRUITING

Feb 2026MRG003 Combined With Immunotherapy in Recurrent/Metastatic Nasopharyngeal Carcinoma: A Phase II Clinical Trial

West China Hospital — PHASE2

TrialNOT YET RECRUITING

Jan 2026Short-course Tislelizumab Combined With Chemoradiotherapy for Nasopharyngeal Carcinoma

Sun Yat-sen University — PHASE3

TrialNOT YET RECRUITING

Jan 2026IMRT Alone for Stage IB Nasopharyngeal Carcinoma Without High-Risk Features

Qiaojuan Guo

TrialRECRUITING

Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Financial Assistance

1 program

FINANCIAL LANDSCAPE SUMMARY

1

Total programs

1

Open now

1

Copay cards

Copay Assistance1

LOQTORZI

Coherus

OpenContact for detailsApply ↗

View all support programs on disease page →

Approved Treatments

1 FDA-approved

Loqtorzi

(toripalimab-tpzi)Orphan drug

Coherus BioSciences, Inc.

Programmed Death Receptor-1 Blocking Antibody [EPC]

12.1 Mechanism of Action Binding of the PD-1 ligands, PD-L1 and PD-L2, to the PD-1 receptor found on T cells, inhibits T cell proliferation and cytoki...

Approved Oct 2023FDA label ↗

View full treatment details on disease page →

Clinical Trial Landscape

89 active trials

31Phase 3

24Phase 2

3Phase 1

9N/A

19Unknown

1PHASE1, PHASE2

2PHASE2, PHASE3

89Total recruiting

Search clinical trials for Nasopharyngeal carcinoma →

Recent News & Research

No recent news articles indexed yet for Nasopharyngeal carcinoma.
Search PubMed for Nasopharyngeal carcinoma →

Browse all Nasopharyngeal carcinoma news →

Specialist Network

Top 6 by expertise

Boon Cher Goh

National University of Singapore

Score 393 trials

Anurag Singh

Roswell Park Cancer Institute

Score 337 trials398 pubs

Stephen Gottschalk, MD, MD

Baylor College of Medicine

📍 MEMPHIS, TN

Score 164 trials

Sungheon Kim

NYU Langone Health

Score 121 trial1127 pubs

Carlos Rodriguez-Galindo, MD

Children's Oncology Group

📍 MEMPHIS, TN

Score 103 trials5 pubs

Chao-su Hu, M.D.

Fudan University

View all Nasopharyngeal carcinoma specialists →

Quick Actions

View Disease Page

Full profile, treatments, community

Search Clinical Trials

Find recruiting studies now

Find Specialists

Ranked by expertise & trials

Financial Assistance

Copay cards, PAPs, grants

Latest News

Research, approvals & updates

Browse All Diseases

11,000+ rare disease profiles